|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Investments, at fair value | |||||||||||||
| Investment Owned, Fair Value | |||||||||||||
| Non-Controlled/Non-Affiliated Investments | |||||||||||||
| Non-controlled Affiliated Investments | |||||||||||||
| Total investment Owned, Fair Value | |||||||||||||
| Total investments, at fair value (cost of $18,389,190 and $15,704,123) | |||||||||||||
| Investments in affiliated money market fund (cost of $333,491 and $444,718) | |||||||||||||
| Investments in affiliated money market fund (cost of $156,592 and $273,743) | |||||||||||||
| Cash | |||||||||||||
| Interest and dividends receivable | |||||||||||||
| Deferred financing costs | |||||||||||||
| Receivable for investments sold | |||||||||||||
| Receivable from investment adviser | |||||||||||||
| Deferred offering costs | |||||||||||||
| Unrealized appreciation on derivatives | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities | |||||||||||||
| Debt (net of debt issuance costs of $66,144 and $34,274) | |||||||||||||
| Payable for investments purchased | |||||||||||||
| Distribution payable | |||||||||||||
| Payable for share repurchases | |||||||||||||
| Interest and other debt expenses payable | |||||||||||||
| Management fees payable | |||||||||||||
| Incentive fees based on capital gains payable | |||||||||||||
| Directors' fees payable | |||||||||||||
| Incentive fees based on income payable | |||||||||||||
| Unrealized depreciation on derivatives | |||||||||||||
| Stockholder servicing and/or distribution fees payable | |||||||||||||
| Accrued expenses and other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Net assets | |||||||||||||
| Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding) | |||||||||||||
| Common stock, par value $0.001 per share (374,154,077 and 345,702,942 shares issued and outstanding as of June 30, 2026 and December 31, 2025) | |||||||||||||
| Common stock, shares outstanding | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Common Class D | |||||||||||||
| Total common stock, shares outstanding | |||||||||||||
| Paid-in capital in excess of par | |||||||||||||
| Distributable earnings (loss) | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Common Class D | |||||||||||||
| Total net assets | |||||||||||||
| Total liabilities and net assets | |||||||||||||
| Net asset value per common share | |||||||||||||
| Net asset value per share | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Common Class D | |||||||||||||
| Total net asset value per share | |||||||||||||
Loading...
